ELAN
Price
$22.68
Change
+$0.13 (+0.58%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
11.27B
15 days until earnings call
Intraday BUY SELL Signals
SBFM
Price
$0.17
Change
-$0.05 (-22.73%)
Updated
Oct 22 closing price
Capitalization
647.52K
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAN vs SBFM

ELAN vs SBFM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELAN vs. SBFM commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a StrongBuy and SBFM is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ELAN with price predictions
Oct 22, 2026

ELAN's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ELAN turned positive on October 05, 2026. Looking at past instances where ELAN's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on ELAN as a result. In 52 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.

Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELAN advanced for three days, in 172 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 54 cases where ELAN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.

ELAN moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for ELAN moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

ELAN broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ELAN entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. ELAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.710) is normal, around the industry mean (10.407). P/E Ratio (-55.000) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (4.042) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (2.275) is also within normal values, averaging (178.797).

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for SBFM with price predictions
Oct 22, 2026

SBFM sees MACD Histogram crosses below signal line

SBFM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 18, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In 40 of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBFM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for SBFM entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

SBFM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.024) is normal, around the industry mean (10.407). P/E Ratio (-0.018) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (0.070) is also within normal values, averaging (178.797).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. SBFM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SBFM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
ELAN vs SBFM: Fundamental Ratings
ELAN
SBFM
OUTLOOK RATING
1..100
896
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9296
PRICE GROWTH RATING
1..100
5798
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (29) in the null industry is in the same range as ELAN (58) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew similarly to ELAN’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (92) in the Agricultural Commodities Or Milling industry is in the same range as SBFM (96) in the null industry. This means that ELAN’s stock grew similarly to SBFM’s over the last 12 months.

ELAN's Price Growth Rating (57) in the Agricultural Commodities Or Milling industry is somewhat better than the same rating for SBFM (98) in the null industry. This means that ELAN’s stock grew somewhat faster than SBFM’s over the last 12 months.

SBFM's P/E Growth Rating (97) in the null industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANSBFM
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
66%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ELAN: $22.69 vs. SBFM: $0.22)
Brand notoriety: ELAN: Notable vs. SBFM: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 86% vs. SBFM: 5%
Market capitalization -- ELAN: $11.27B vs. SBFM: $647.52K
ELAN [@Pharmaceuticals: Generic] is valued at $11.27B. SBFM’s [@Pharmaceuticals: Generic] market capitalization is $647.52K. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green while SBFM’s FA Score has 1 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • SBFM’s FA Score: 1 green, 4 red.
According to our system of comparison, SBFM is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 3 TA indicator(s) are bullish while SBFM’s TA Score has 2 bullish TA indicator(s).

  • ELAN’s TA Score: 3 bullish, 6 bearish.
  • SBFM’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, SBFM is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а -3.61% price change this week, while SBFM (@Pharmaceuticals: Generic) price change was -11.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.00%. For the same industry, the average monthly price growth was -9.86%, and the average quarterly price growth was +9.31%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 06, 2026.

SBFM is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.00% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
ELAN
Daily Signal:
Gain/Loss:
SBFM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and SXTC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and SXTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-22.47%
SXTC - SBFM
31%
Poorly correlated
-34.25%
OGI - SBFM
28%
Poorly correlated
-0.43%
CGC - SBFM
24%
Poorly correlated
-1.00%
TLRY - SBFM
24%
Poorly correlated
+0.34%
ELAN - SBFM
23%
Poorly correlated
+0.62%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
NEXO.X0.807817-0.016537
-2.01%
Nexo cryptocurrency
MDT.X0.006558-0.000233
-3.43%
Measurable Data Token cryptocurrency
CELR.X0.002502-0.000153
-5.77%
Celer Network cryptocurrency
ROSE.X0.007215-0.000563
-7.24%
Oasis cryptocurrency
OM.X0.001775-0.050382
-96.60%
MANTRA (old) cryptocurrency